Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

iPACK and Femoral Triangle Block for Pain Control in ACL Reconstruction

16. november 2026 opdateret af: moazzam ali, Combined Military Hospital Quetta

Analgesic Efficacy and Functional Recovery of Adding iPACK to Femoral Triangle Block in Anterior Cruciate Ligament Reconstruction

The goal of this clinical trial is to learn if adding an iPACK block (a nerve block for the back of the knee) to a femoral triangle block improves pain control and knee function after surgery in adults aged 18 to 50 years undergoing anterior cruciate ligament (ACL) reconstruction. It will also learn about the safety of the combined blocks. The main questions it aims to answer are:

Does adding an iPACK block to a femoral triangle block lower postoperative pain scores over the first 48 hours? Does the combined block reduce the amount of opioid pain medication needed and delay the time to first rescue pain medication? Does the combined block improve early knee function (quadriceps strength, knee range of motion, and patient-reported knee scores) without causing muscle weakness or other complications?

Researchers will compare a femoral triangle block plus an iPACK block to a femoral triangle block alone (with a sham procedure to keep patients unaware of their group) to see if the added iPACK block provides better pain relief and recovery after ACL reconstruction.

Participants will:

Receive either a femoral triangle block plus an iPACK block, or a femoral triangle block alone, under ultrasound guidance before or after surgery Rate their pain at rest and during movement at 6, 12, 24, and 48 hours after surgery Have their pain medication use, quadriceps strength, knee movement, and time to first walking recorded during the hospital stay Complete knee function questionnaires (IKDC, Lysholm, and KOOS) before surgery and at follow-up visits at 2 weeks, 6 weeks, and 3 months Be monitored for side effects such as nausea, vomiting, falls, and nerve-related problems

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

40

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 50 år (Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Adults aged 18 to 50 years, of either sex, Scheduled for primary, unilateral, elective arthroscopic anterior cruciate ligament (ACL) reconstruction (autograft, e.g., hamstring or patellar tendon),American Society of Anesthesiologists (ASA) physical status I or II, Body mass index (BMI) of 35 kg/m² or less Planned spinal or general anesthesia Able to understand and use the Numeric Rating Scale (NRS) for pain, and able to comply with postoperative assessments and follow-up visits Willing and able to provide written informed consent

Exclusion Criteria:

  • Patient refusal or inability to provide informed consent Known allergy or hypersensitivity to local anesthetics or other study medications Coagulopathy, or use of anticoagulants or antiplatelet agents that contraindicate regional anesthesia Infection at the planned block injection site Pre-existing neurological deficit or neuropathy in the operative limb Revision ACL surgery, multiligament reconstruction, or major concomitant procedures (e.g., osteotomy, cartilage restoration) Chronic opioid use or chronic pain conditions Contraindication to paracetamol or NSAIDs that would prevent standardized multimodal analgesia Psychiatric or cognitive disorder that limits pain assessment Pregnancy

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Firedobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Group FTB

An ultrasound-guided femoral triangle block performed on the operative limb with the patient supine. A high-frequency linear transducer is placed transversely over the anterior thigh, below the inguinal crease, at the level where the sartorius muscle crosses the femoral artery and the femoral triangle is bordered by the sartorius, adductor longus, and inguinal ligament. A 22-gauge, 80 to 100 mm echogenic block needle is advanced in-plane, lateral to medial, to the lateral side of the femoral artery, beneath the fascia iliaca and above the iliopsoas muscle, and local anesthetic is deposited around the femoral artery to target the saphenous nerve, the nerve to the vastus medialis, and the anterior femoral cutaneous branches.

Eksperimentel: Group FTB with Ipack

An ultrasound-guided iPACK block performed in addition to the FTB, The patient is positioned supine with the knee flexed and hip externally rotated. A curvilinear or linear transducer is placed in the popliteal fossa at the level of the femoral condyles, and the popliteal artery and posterior surface of the femur are identified. A 22-gauge, 80 to 100 mm block needle is advanced in-plane from the medial side to the plane between the popliteal artery and the femoral shaft or condyles, posterior to the artery and anterior to the posterior knee capsule. After negative aspiration, 15 to 20 mL of the same local anesthetic is injected

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
postoperative pain intensity at rest and on movement, measured by the Numeric Rating Scale (NRS, 0 to 10)
Tidsramme: 6, 12, 24, and 48 hours after the end of surgery
6, 12, 24, and 48 hours after the end of surgery
Total opioid consumption
Tidsramme: 48 hours after surgery
48 hours after surgery

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

15. oktober 2026

Primær færdiggørelse (Anslået)

1. december 2026

Studieafslutning (Anslået)

1. december 2026

Datoer for studieregistrering

Først indsendt

16. november 2026

Først indsendt, der opfyldte QC-kriterier

16. november 2026

Først opslået (Faktiske)

20. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

20. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

16. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • ipack/2026

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner